Cora Therapeutics

What Cora Therapeutics does

Cora Therapeutics is a Toronto-based, privately-held nutraceutical company operating under the consumer-facing brand Cora Nutraceuticals. The company commercializes a single product, DNA Halo® Novel Antioxidant Complex — a patented complex of ten bioactive ingredients developed by physician-scientists at the University of Toronto, Dalhousie University, and McMaster University. The formulation is positioned as a radiation-defense supplement and is supported by peer-reviewed human clinical trials measuring DNA strand-break reduction via gamma-H2AX and p53 biomarkers; the product claims protection of both nuclear and mitochondrial DNA, noting the latter is 13x more vulnerable to radiation damage. The product is cGMP certified and third-party tested for purity and potency.

The company's go-to-market is primarily direct-to-consumer e-commerce through a Shopify storefront (coranutraceuticals.com), priced at $49.95 USD per 60-capsule bottle with a $100 free-shipping threshold, supplemented by a wholesale channel for bulk/reseller buyers. Cora Therapeutics targets three segments under a single vertical: medical and military professionals with occupational radiation exposure (primary), and health-conscious consumers concerned about radiation and oxidative stress (secondary). The brand emphasizes clinical evidence over general antioxidant claims as its core differentiation strategy.

Cora Therapeutics is an early-stage startup (1–10 employees) that raised a $1.8 million seed round led by IronGate Capital Advisors, announced March 27, 2023, to fund the North American launch of DNA Halo across its target segments. Operating geographies are North America (United States and Canada), with USD-denominated pricing and shipping already active on the consumer storefront. The company has no disclosed revenue, no named enterprise customers, and no public listing.

Name

Cora Therapeutics

Legal name

Cora Therapeutics

Website

https://coratherapeutics.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Cora Therapeutics is a Toronto-based nutraceutical company selling DNA Halo®, a patented antioxidant complex clinically proven to reduce radiation-induced DNA damage, targeting medical imaging professionals, military personnel, and health-conscious consumers via direct-to-consumer e-commerce and wholesale across North America.

Ownership category

akta.pro rank

Product category

Nutraceuticals / Dietary Supplements

NAICS

Medicinal and Botanical Manufacturing (325411), Food (Health) Supplement Retailers (456191)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Herbal & Botanical Supplements (CRADAGAD)

akta.pro secondary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

Keywords

• DNA protection supplements
• Antioxidant nutraceuticals
• Radiation defense supplements
• Clinical-grade supplements
• Cellular health products

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

1. DNA Halo Product Sales: Direct-to-consumer and wholesale sales of the DNA Halo Novel Antioxidant Complex nutraceutical product. Sold as a one-time purchase at $49.95 per 60-capsule bottle via the company's e-commerce storefront, with wholesale channel available for bulk buyers.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Cora Therapeutics manufactures and sells DNA Halo®, a patented, clinically tested nutraceutical supplement formulated as a complex of ten bioactive ingredients. The product is designed to reduce DNA strand breaks caused by radiation and oxidative stress, protecting both nuclear and mitochondrial DNA. It is sold directly to consumers via an e-commerce storefront and through a wholesale channel for bulk buyers, targeting medical, military, and general health-conscious consumers in North America.

Product overview

Cora Therapeutics, operating as Cora Nutraceuticals, offers a single unified nutraceutical product: DNA Halo® Novel Antioxidant Complex. DNA Halo® is a precisely formulated patented complex of ten bioactive ingredients developed by academic researchers and proven in clinical trials. The product is positioned as a radiation defense supplement for individuals with occupational radiation exposure, targeting medical, military, and consumer markets.

Differentiator

Problem solved

Functional benefit

Products and services

• DNA Halo® Novel Antioxidant Complex Patented nutraceutical supplement containing ten bioactive ingredients, developed by physician-scientists at University of Toronto, Dalhousie University, and McMaster University. Proven in peer-reviewed human clinical trials to reduce DNA strand breaks (measured via γH2AX and p53 biomarkers) caused by radiation and oxidative stress. Protects both nuclear and mitochondrial DNA. Sold as a 60-capsule bottle at $49.95 USD via the company's e-commerce storefront, with a wholesale channel for bulk buyers.

Quantifiable outcome

• Reduces DNA strand breaks — measured using gamma-H2AX and p53, the gold-standard molecular biomarkers used by cancer researchers worldwide
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Life Extension: Long-established direct-to-consumer supplement brand built on clinically-validated formulations and a research-driven brand narrative — directly comparable to Cora's positioning of DNA Halo® as a clinically proven antioxidant. Life Extension's scale, multi-SKU catalog, and consumer-marketing reach make it the most analogous competitor for premium, evidence-backed nutraceuticals.
• Thorne: Premium, practitioner-recommended supplement brand emphasizing clinical validation, third-party testing, and cGMP manufacturing — closely aligned with Cora's quality certifications and clinical-evidence positioning. Both target health-conscious consumers and professional channels.
• Pure Encapsulations: Hypoallergenic, practitioner-grade supplement brand with strong clinical credibility and wholesale distribution through healthcare practitioners — comparable in clinical positioning, cGMP quality stance, and DTC + practitioner channel mix.
• Designs for Health: Practitioner-channel supplement company founded by clinicians, with an emphasis on science-backed formulations sold through healthcare professionals — comparable to Cora's physician-scientist origins and clinical-evidence narrative.
• Metagenics: Clinical nutrition company offering evidence-based supplements and medical foods, primarily through practitioner channels. Comparable clinical-grade positioning and emphasis on peer-reviewed evidence, though significantly larger and more diversified.
• Integrative Therapeutics: Integrative medicine supplement brand with strong practitioner distribution, clinical research backing, and condition-specific product lines — closely analogous in evidence-based branding and professional-channel focus.
• Standard Process: Whole-food and clinical nutrition brand sold primarily through healthcare practitioners, with vertically integrated manufacturing and condition-targeted product lines — comparable in practitioner-channel distribution and clinically-validated brand positioning.

Emerging players

• Researched Nutritionals: Practitioner-channel supplement brand focused on condition-specific, clinically-studied formulations (e.g., immune, mitochondrial support). Similar narrative of using published research to differentiate niche, condition-targeted supplements.

Broad incumbents

• NOW Foods: Large-scale supplement manufacturer with broad antioxidant SKU portfolio, cGMP manufacturing, and global distribution. Comparable in product format and quality certifications, though positioned as a value-led incumbent rather than a clinically-narrated specialty brand.
• Jarrow Formulas: Broad-line supplement manufacturer with science-informed positioning and DTC + practitioner channels. Comparable as a category incumbent in the antioxidant and condition-specific supplement space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cora Therapeutics